Table 3.
Patients with Grade 3 or 4 thrombocytopenia, neutropenia, and/or anemia, based on laboratory results.
| Group A (gemcitabine + cisplatin/carboplatin) |
Group B (gemcitabine monotherapy) |
|||
|---|---|---|---|---|
| Eltrombopag (n = 9) | Placebo (n = 3) | Eltrombopag (n = 10) | Placebo (n = 4) | |
| Thrombocytopenia, n (%)1,2 | 4 (44) | 3 (100) | 2 (20) | 2 (50) |
| Thrombocytopenia, n (%)1,3 | 3 (33) | 2 (67) | 0 (0) | 1 (25) |
| Neutropenia, n (%)2,4 | 4 (44) | 2 (67) | 0 (0) | 0 (0) |
| Anemia, n (%)1,2 | 2 (22) | 1 (33) | 3 (30) | 2 (50) |
1
Central laboratory results.
2
Cycle 1 to the end of the 30-day follow-up.
3
Cycle 2 to the end of the 30-day follow-up.
4
Local laboratory results.